James J Pomfret Joins I-ACT for Children’s Board of Directors
Rockville, MD. The Institute for Advanced Clinical Trials for Children (I-ACT for Children) announced that James J. Pomfret ChFC®, CLU®, AIF®, Managing Director – Investment Officer at Wells Fargo Advisors, has joined the Institute as a member of its Board of Directors. Mr. Pomfret was previously a Budget Analyst with the Social Security Administration, after…
Read MoreLisa Benson, BS, CCRP, CRCP joins I-ACT for Children as Vice President, Clinical Research Operations, Quality and Education.
The Institute for Advanced Clinical Trials for Children (aka, I-ACT for Children) is pleased to announce the appointment of Lisa Benson to the position of Vice President, Clinical Research Operations, Quality and Education, beginning June 5. Lisa is a highly-respected research administrator and clinical operations expert. She comes to I-ACT for Children from the Department…
Read MorePediatric Trials Consortium Reports Completion of Its Objectives Related to I-ACT for Children
This week, Critical Path Institute’s Pediatric Trials Consortium (PTC) reported the completion of its objectives in record time (PTC Deliverables). These includes the posting of the Executive Summary of PTC’s Advisory Report and support for the launch of the Institute for Advanced Clinical Trials for Children, aka I-ACT for Children. The PTC Advisory Report represents the…
Read MoreInstitute for Advanced Clinical Trials for Children Established to Catalyze Innovative Pediatric Therapeutics Clinical Research and Education
New non-profit institute to work with public and private stakeholders to enable research and education on innovative treatments to enhance healthcare for children. (Tucson, AZ) [Regionally: Baltimore, MD], 4/10/2017. Critical Path Institute (C-Path) has established a new 501(c)3 non-profit, the Institute for Advanced Clinical Trials for Children (I-ACT for Children), to support and advance research…
Read MoreBarry Brooks, JD Joins I-ACT for Children’s Board of Directors
The Institute for Advanced Clinical Trials for Children (I-ACT for Children) welcomes Barry Brooks to its Board of Directors. Mr. Brooks is Partner of Paul Hastings, LLP, an international law firm. Mr. Brooks is a member of that firm’s Corporate Department, and is the Chair of its 280-attorney New York office. With a strong presence…
Read MoreMessage from the Chairman…
Welcome to the Institute for Advanced Clinical Trials for Children, aka I-ACT for Children!
Read MoreKaren King, MS appointed as Vice President, Strategy and Operations, I-ACT for Children
The Institute for Advanced Clinical Trials for Children (I-ACT for Children) welcomes Karen King to its senior leadership team, as Vice President, Strategy and Operations. Ms. King has nearly 20 years of successful experience in the development and commercialization of biopharmaceutical products. She has strong strategic planning, project management, and analytical skills, with specific expertise…
Read More